menu
    • menu

    Company profile for DelSiTech

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    DelSiTech is an innovative drug delivery and development company that works with its partners to turn their active agents into novel and commercially attractive therapeutic drug products. DelSiTech provides the technology and expertise for solving drug delivery problems. The company’s technology is based on amorphous silica (SiO2) matrix and sol-gel encapsulation technique which have significant competitive advantages over o...
    DelSiTech is an innovative drug delivery and development company that works with its partners to turn their active agents into novel and commercially attractive therapeutic drug products. DelSiTech provides the technology and expertise for solving drug delivery problems. The company’s technology is based on amorphous silica (SiO2) matrix and sol-gel encapsulation technique which have significant competitive advantages over other technologies. In addition, the Company is developing its own pipeline of supergeneric/505(b)(2) products to address significant unmet medical and commercial needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    DelSiTechFinland Flag
    Country
    Country
    Finland
    Address
    Address
    Eastern Pitkäkatu 4 B (PharmaCity), 20520 Turku,
    Telephone
    Telephone
    +358 2 2510 110
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.delsitech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/delsitech-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Food Ingredients China

    Not Confirmed

    envelop Contact Supplier

    Food Ingredients China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Delsitech Announces a Major Licensing Agreement on Drug Delivery
    Delsitech Announces a Major Licensing Agreement on Drug Delivery

    23 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/delsitech-announces-a-major-licensing-agreement-on-drug-delivery-302153119.html

    PR NEWSWIRE
    23 May 2024
    Share Share
    DelSiTech and Tolmar Announce Global License and Development Agreement
    DelSiTech and Tolmar Announce Global License and Development Agreement

    13 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/delsitech-and-tolmar-announce-global-license-and-development-agreement-302059757.html

    PR NEWSWIRE
    13 Feb 2024
    Share Share
    DelSiTech Announces Closing of EUR 10 Million Financing Round
    DelSiTech Announces Closing of EUR 10 Million Financing Round

    16 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/delsitech-announces-closing-of-eur-10-million-financing-round-to-advance-its-silica-based-drug-delivery-technology-platform-302034841.html

    PR NEWSWIRE
    16 Jan 2024
    Share Share
    DelSiTech announces +ve topline datafrom ph1 trial with its SR eye drop platform
    DelSiTech announces +ve topline datafrom ph1 trial with its SR eye drop platform

    29 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/delsitech-announces-positive-topline-clinical-data-from-phase-1-trial-with-its-sustained-release-eye-drop-platform-301866331.html

    PR NEWSWIRE
    29 Jun 2023
    Share Share
    DelSiTech Awarded a Grant to Develop Injectables for Prophylactic HIV Vaccine
    DelSiTech Awarded a Grant to Develop Injectables for Prophylactic HIV Vaccine

    15 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/delsitech-awarded-a-grant-to-develop-controlled-and-sustained-release-injectables-for-prophylactic-hiv-vaccine-301772580.html

    PR NEWSWIRE
    15 Mar 2023
    Share Share
    Iveric granted rights to commercialise formulations of AMD treatment
    Iveric granted rights to commercialise formulations of AMD treatment

    15 Jul 2022

    // PMM

    https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/biopharma-news/exclusive-agreement-permits-commercialisation-of-amd-treatme/

    PMM
    15 Jul 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search